Earnings summaries and quarterly performance for SILGAN HOLDINGS.
Executive leadership at SILGAN HOLDINGS.
Adam Greenlee
Chief Executive Officer and President
Alexander Hutter
Senior Vice President, Strategy and Investor Relations
B. Frederik Prinzen
Senior Vice President, Corporate Development
Daniel Murphy
Vice President and Controller; Treasurer
Frank Hogan
Executive Vice President, General Counsel and Secretary
Jay Martin
Senior Vice President; President of Silgan Plastics
Kimberly Ulmer
Senior Vice President and Chief Accounting Officer
Philippe Chevrier
Executive Vice President and Chief Operating Officer
Robert Lewis
Executive Vice President, Corporate Development and Administration
Shawn Fabry
Executive Vice President and Chief Financial Officer
Board of directors at SILGAN HOLDINGS.
Research analysts who have asked questions during SILGAN HOLDINGS earnings calls.
Arun Viswanathan
RBC Capital Markets
7 questions for SLGN
Ghansham Panjabi
Robert W. Baird & Co.
7 questions for SLGN
Gabe Hajde
Wells Fargo & Company
6 questions for SLGN
George Staphos
Bank of America
6 questions for SLGN
Anthony Pettinari
Citigroup Inc.
5 questions for SLGN
Daniel Rizzo
Jefferies
5 questions for SLGN
Jeffrey Zekauskas
JPMorgan Chase & Co.
5 questions for SLGN
Matt Roberts
Raymond James Financial
4 questions for SLGN
Matthew Roberts
Raymond James
3 questions for SLGN
Michael Roxland
Truist Securities
3 questions for SLGN
Mike Roxland
Truist Securities
3 questions for SLGN
Anojja Shah
UBS Group AG
2 questions for SLGN
Alex Hantman
Sidoti & Company
1 question for SLGN
Bryan Burgmeier
Citigroup Inc.
1 question for SLGN
Gregory Wasikowski
Webber Research & Advisory LLC
1 question for SLGN
Niccolo Piccini
Truist Securities
1 question for SLGN
Recent press releases and 8-K filings for SLGN.
- Silgan Holdings Inc. reported full year 2025 net sales of $6.5 billion and net income of $288.4 million, resulting in diluted EPS of $2.70 and adjusted diluted EPS of $3.72.
- For the fourth quarter of 2025, net sales were $1.47 billion, with net income at $18.2 million and diluted EPS at $0.17.
- The company achieved record full year Dispensing and Specialty Closures and Custom Containers adjusted EBIT and exceeded its Free Cash Flow estimate for 2025, reaching $445.2 million.
- Silgan anticipates continued growth in 2026, with estimated adjusted net income per diluted share in the range of $3.70 to $3.90 and free cash flow of approximately $450 million.
- Silgan Holdings reported Q4 2025 net sales of approximately $1.5 billion, a 4% increase year-over-year, with adjusted EBIT of $150.6 million and adjusted EPS of $0.67. For the full year 2025, the company achieved its second highest adjusted earnings and free cash flow in its history.
- The company provided 2026 estimated EPS in the range of $3.70-$3.90 and an estimated free cash flow of approximately $450 million, with Q1 2026 Adjusted EPS projected between $0.70-$0.80.
- In 2025, Silgan successfully integrated the Weener acquisition, achieved full run rate synergies, returned to its target leverage range, and completed its multi-year cost reduction program.
- Sean Fabry was promoted to CFO in November 2025, succeeding Bob Lewis who is set to retire at the end of March 2026.
- For 2026, Dispensing and Specialty Closures organic volumes are projected to grow by a low to mid-single-digit rate, Metal Containers volumes by a low single-digit percentage, and Custom Containers volumes are expected to be flat.
- Silgan reported Q4 2025 net sales of approximately $1.5 billion, an increase of 4% from the prior year, with Adjusted EPS of $0.67. For the full year 2025, the company delivered its second highest adjusted earnings and free cash flow, returned approximately $160 million in capital to shareholders, and successfully integrated the Weener acquisition, achieving full run rate synergies and completing its multi-year cost reduction program.
- The company provided 2026 estimated EPS in the range of $3.70-$3.90, compared to $3.72 in 2025, and anticipates approximately $450 million in free cash flow.
- For 2026, Silgan expects low to mid-single-digit volume growth in Dispensing and Specialty Closures, low single-digit growth in Metal Containers, and flat volumes in Custom Containers.
- Sean Fabry was promoted to CFO in November 2025, succeeding Bob Lewis, who will retire at the end of March 2026.
- Silgan Holdings reported Q4 2025 net sales of approximately $1.5 billion, a 4% increase from the prior year, with adjusted EBIT of $150.6 million and adjusted EPS of $0.67.
- For the full year 2025, the company delivered its second highest adjusted earnings and free cash flow, returned approximately $160 million in capital to shareholders, and successfully integrated the Weener acquisition, achieving full run rate synergies.
- The company issued 2026 estimated EPS guidance of $3.70-$3.90 and projected approximately $450 million in free cash flow.
- Segment expectations for 2026 include low to mid-single-digit organic volume growth in Dispensing and Specialty Closures, low single-digit volume growth in Metal Containers (driven by pet food), and comparable volumes for Custom Containers.
- Sean Fabry was promoted to CFO in November 2025, succeeding Bob Lewis, who is set to retire at the end of March 2026.
- Silgan Holdings reported full year 2025 net sales of $6.5 billion and diluted net income per share of $2.70, up from $5.9 billion and $2.58 respectively in 2024.
- For the fourth quarter of 2025, net sales were $1.47 billion, an increase of 4% over the prior year, while diluted net income per share decreased to $0.17 from $0.42 in Q4 2024.
- The company achieved $445.2 million in free cash flow for 2025, a 14% increase year-over-year, and returned approximately $160 million to shareholders.
- For 2026, Silgan anticipates adjusted net income per diluted share in the range of $3.70 to $3.90 and approximately $450 million in free cash flow, expecting continued growth.
- Key drivers for 2025 included the successful integration of the Weener acquisition, over 17% sales growth in the Dispensing and Specialty Closures segment, and 7% growth in metal containers for pet food markets.
- On November 5, 2025, Silgan Holdings Inc. announced that its Board of Directors authorized a new stock repurchase program.
- The company is authorized to repurchase up to an aggregate of $500 million of its common stock.
- This authorization is valid through December 31, 2029, and replaces a prior authorization that had approximately $25 million remaining.
- Silgan Holdings Inc.'s Board of Directors has authorized a new stock repurchase program for up to $500 million of its common stock.
- This authorization is effective through December 31, 2029, and replaces a prior authorization that had approximately $25 million remaining.
- CEO Adam Greenlee stated that the company maintains a disciplined, returns-based approach to capital deployment.
- Silgan Holdings Inc. reported net sales of $2.01 billion for the third quarter of 2025, marking a 15% increase compared to $1.75 billion in the third quarter of 2024.
- Net income for Q3 2025 was $113.3 million, or $1.06 per diluted share, up from $100.1 million, or $0.93 per diluted share, in the same period last year.
- Adjusted net income per diluted share increased 1% to $1.22 in Q3 2025 from $1.21 in Q3 2024.
- The company confirmed its 2025 free cash flow estimate of $430 million and returned over $120 million to shareholders year-to-date through share repurchases and dividends.
- The Dispensing and Specialty Closures segment achieved a record adjusted EBIT of $113.5 million in Q3 2025, a 19% increase from Q3 2024, partly due to the Weener acquisition.
- Silgan reported Q3 2025 net sales of $2 billion, a 15% increase year-over-year, and total adjusted EBIT of $221 million, up 8%. The company delivered 10% adjusted EPS growth through the first three quarters of 2025 and returned over $120 million to shareholders through dividends and share repurchases.
- The Dispensing and Specialty Closures segment saw sales increase 23% with record adjusted EBIT, driven by nearly 40% growth in dispensing product sales and 15% organic growth in fragrance volumes, despite a 5% decline in food and beverage closures volumes. Metal Containers sales grew 13% with 4% unit volume growth, including a 10% increase in pet food products. Custom Containers adjusted EBIT increased 15%.
- For Q4 2025, adjusted EPS is estimated to be between $0.62 and $0.72 per diluted share, negatively impacted by lower volumes in personal care and home care, higher interest expense, and a higher tax rate. Full year 2025 free cash flow guidance is maintained at approximately $430 million, a 10% increase from the prior year.
- Silgan Holdings reported Q3 2025 net sales of $2 billion, a 15% increase year-over-year, with total adjusted EBIT rising 8% to $221 million and adjusted EPS at $1.22. The Dispensing and Specialty Closures segment was a strong performer, with sales up 23% and adjusted EBIT up 19%, driven by the Vayner acquisition and 15% organic growth in fragrance volumes.
- For Q4 2025, the company forecasts adjusted EPS between $0.62 and $0.72, citing headwinds from higher interest expense, a higher tax rate, and an estimated $25 million impact due to lower volumes and proactive inventory reductions in the dispensing and specialty closures and custom containers segments.
- Despite the Q4 adjustments, Silgan maintains its full-year 2025 free cash flow estimate of approximately $430 million, representing a 10% increase from the prior year, largely attributed to these inventory reductions. The company also anticipates higher earnings and free cash flow in 2026 and repurchased $60 million of shares in Q3 2025.
Quarterly earnings call transcripts for SILGAN HOLDINGS.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more
